Cardlytics Shares Rise After Citron Research Says Company Has Multiple Opportunities to Rebuild

Cardlytics (CDLX) shares were up over 26% in recent Wednesday trading after Citron Research said it
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Google